Pharmacoepigenetics in heart failure

Irene Mateo Leach, Pim van der Harst, Rudolf A de Boer

Research output: Contribution to journalReview articlepeer-review

Abstract

Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenotypic variation, but that epigenetic changes also play an important role in the variation of predisposition to disease and to drug response. In this review, we discuss recent evidence of epigenetic changes that play an important role in the development of cardiac hypertrophy and heart failure and may dictate response to therapy.

Original languageEnglish
Pages (from-to)83-90
Number of pages8
JournalCurrent Heart Failure Reports
Volume7
Issue number2
DOIs
Publication statusPublished - Jun 2010
Externally publishedYes

Keywords

  • DNA Methylation
  • Epigenesis, Genetic
  • Genetic Predisposition to Disease
  • Heart Failure/genetics
  • Humans
  • MicroRNAs/genetics
  • Pharmacogenetics

Fingerprint

Dive into the research topics of 'Pharmacoepigenetics in heart failure'. Together they form a unique fingerprint.

Cite this